The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dawes Karen A since 2016.
This trader's CIK number is 1261506.
At the time of last reporting, Dawes Karen A was the Officer of Repligen Corp. (stock ticker symbol RGEN).
Also see all insider trading activities at Repligen Corp.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RGEN | 0 | $0 | 275 | $44,275 | 0 | $0 |
| 2024 | RGEN | 0 | $0 | 1,000 | $193,350 | 7,579 | $394,562 |
| 2022 | RGEN | 0 | $0 | 14,715 | $2,223,407 | 0 | $0 |
| 2021 | RGEN | 0 | $0 | 36,262 | $9,155,367 | 26,171 | $427,946 |
| 2020 | RGEN | 0 | $0 | 37,022 | $4,122,100 | 20,000 | $66,000 |
| 2019 | RGEN | 0 | $0 | 1,295 | $100,168 | 20,000 | $99,200 |
| 2018 | RGEN | 0 | $0 | 20,000 | $835,939 | 20,000 | $101,600 |
| 2017 | RGEN | 0 | $0 | 2,521 | $86,016 | 20,000 | $85,800 |
| 2016 | RGEN | 0 | $0 | 0 | $0 | 15,000 | $46,500 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | ASRT | 0 | $0 | 15,834 | $12,524 | 0 | $0 |
| 2019 | ASRT | 0 | $0 | 12,500 | $39,800 | 31,250 | $0 |
| 2018 | ASRT | 0 | $0 | 8,421 | $40,723 | 15,000 | $22,350 |
2. Assertio Therapeutics, Inc (ASRT)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-17 | RGEN | Sale | 275 | 161.00 | 44,275 |
| 2024-06-14 | RGEN | Option Ex | 2,953 | 67.71 | 199,947 |
| 2024-02-27 | RGEN | Option Ex | 4,626 | 42.07 | 194,615 |
| 2024-02-27 | RGEN | Sale | 1,000 | 193.35 | 193,350 |
| 2022-05-25 | RGEN | Sale | 14,715 | 151.10 | 2,223,407 |
| 2021-11-10 | RGEN | Sale | 4,783 | 265.15 | 1,268,226 |
| 2021-11-10 | RGEN | Option Ex | 4,783 | 26.12 | 124,931 |
| 2021-11-02 | RGEN | Sale | 2,400 | 303.19 | 727,646 |
| 2021-09-14 | RGEN | Sale | 274 | 293.45 | 80,405 |
| 2021-09-01 | RGEN | Sale | 3,459 | 283.02 | 978,966 |
| 2021-09-01 | RGEN | Option Ex | 3,459 | 38.76 | 134,070 |
| 2021-08-17 | RGEN | Sale | 17,514 | 253.67 | 4,442,723 |
| 2021-08-18 | RGEN | Sale | 1,442 | 259.94 | 374,839 |
| 2021-07-20 | RGEN | Sale | 4,585 | 201.69 | 924,771 |
| 2021-07-13 | RGEN | Option Ex | 2,929 | 41.19 | 120,645 |
| 2021-07-13 | RGEN | Sale | 1,520 | 202.23 | 307,389 |
| 2021-05-11 | RGEN | Option Ex | 15,000 | 3.22 | 48,300 |
| 2021-05-11 | RGEN | Sale | 285 | 176.85 | 50,402 |
| 2020-06-18 | RGEN | Sale | 18,705 | 115.10 | 2,152,908 |
| 2020-05-20 | RGEN | Sale | 517 | 138.15 | 71,420 |
| 2020-05-18 | RGEN | Sale | 1,600 | 139.30 | 222,884 |
| 2020-04-20 | RGEN | Option Ex | 8,200 | 3.30 | 27,060 |
| 2020-04-21 | RGEN | Option Ex | 11,800 | 3.30 | 38,940 |
| 2020-04-20 | RGEN | Sale | 12,200 | 104.70 | 1,277,340 |
| 2020-02-21 | RGEN | Sale | 4,000 | 99.39 | 397,548 |
| 2019-06-17 | RGEN | Option Ex | 20,000 | 4.96 | 99,200 |
| 2019-06-17 | RGEN | Sale | 1,295 | 77.35 | 100,168 |
| 2018-05-11 | RGEN | Option Ex | 20,000 | 5.08 | 101,600 |
| 2018-05-11 | RGEN | Sale | 20,000 | 41.80 | 835,939 |
| 2017-03-21 | RGEN | Option Ex | 20,000 | 4.29 | 85,800 |
| 2017-03-21 | RGEN | Sale | 2,521 | 34.12 | 86,016 |
| 2016-06-27 | RGEN | Option Ex | 15,000 | 3.10 | 46,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-08 | ASRT | Sale | 15,834 | .79 | 12,524 |
| 2019-06-13 | ASRT | Sale | 12,500 | 3.18 | 39,800 |
| 2019-05-08 | ASRT | Option Ex | 31,250 | .00 | 0 |
| 2018-12-03 | ASRT | Option Ex | 15,000 | 1.49 | 22,350 |
| 2018-12-03 | ASRT | Sale | 8,421 | 4.84 | 40,723 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dawes Karen A (Officer of Repligen Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.